Sale is live|00:00:00
Exide Industries LtdQ3 FY22

Exide Industries Ltd

Q3 FY22 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • Robust demand across all segments with 32% growth in sales and PBT in recent periods (Page 7).
  • Double-digit growth in both volume and value overall, though not uniform across all segments (Pages 7-8).
  • Increasing market share in vehicular segments like two-wheelers and four-wheelers (Page 9).
  • Strong growth in export markets; presence in 60 countries with rapid growth opportunities (Page 14).
  • EV auxiliary lead-acid batteries segment showing inquiries and production; expected to grow (Page14).
  • Lithium-ion plant expected to ramp up production from 2025-26, contributing to future growth (Page 16).
  • Continued investments in R&D and manufacturing capabilities with a modern, state-of-the-art plant under construction (Page 15-16).
  • Expansion focused on brownfield capacity enhancements, no immediate greenfield plants planned (Page 7).
  • Expectation of stable or improving margins once raw material prices stabilize, supporting profitability (Page 6, 9).

Margin guidance

Category 3
  • Exide Industries reported a healthy 32% growth in sales and profit before tax in H1 FY23, signaling strong demand across automotive and industrial segments.
  • The company expects sequential margin recovery supported by some respite in input costs, though raw material prices remain volatile.
  • Lead-acid battery business margins are anticipated to normalize within 3-6 months once raw material prices stabilize, returning to earlier ~14% levels.
  • Lithium-ion cell manufacturing plant is expected to start production in late FY24-25, with full capacity ramp-up and stabilization by FY25-26, supporting future revenue and profitability growth.
  • Expansion in lithium-ion and battery pack business, targeting multiple vehicle segments and stationary applications, is planned with capex around INR 6,000 crores across phases.
  • Digitalization and cost optimization initiatives are expected to lower fixed costs and improve operating efficiency.
  • Overall, the outlook is optimistic with robust demand and strategic investments driving growth and margin improvement.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Exide Industries Ltd and 1,400+ other companies.

Fundraise plans

Yes
  • The company plans to fund its lithium-ion cell manufacturing plant largely through internal accruals and equity infusion from Exide.
  • For any bridge financing needs, they will consider borrowing from banks or other financial institutions.
  • There is no current plan to monetize their investment in HDFC Life for funding purposes; internal accruals will primarily support capex.
  • The core lead-acid battery business capex will continue with approximately INR 400-500 crores annually, funded internally.
  • No specific mention of new equity or debt fundraising rounds at this time; focus remains on using internal resources and conventional bank borrowing if needed.

Order book

  • The transcript does not explicitly mention the current or expected order book or pending orders in precise figures.
  • There is a strong demand scenario mentioned with robust orders in automotive replacement and industrial segments.
  • The company reports upbeat demand and good order inflow driven by recovery in OEMs and increased capex in public and private sectors.
  • For the lithium-ion segment, there is significant interest from OEMs and other customers, with RFQs already started.
  • Exide is well poised to service growing requirements, leveraging customer connect from its 75 years in the market.
  • The lithium-ion manufacturing plant is expected to start production in late 2024 to 2025, aiming to meet growing customer demand.
  • Overall, while no quantified order book details are disclosed, the company indicates healthy demand and growth prospects across segments.

Capex plans

Yes
  • Exide is setting up a multi-gigawatt lithium-ion cell manufacturing facility in Bangalore on ~80 acres.
  • The plant will have two phases: Phase I with 6 GWh capacity, Phase II with another 6 GWh, totaling 12 GWh.
  • Total capex for the plant is estimated at around INR 6,000 crores (~INR 4,000 crores for Phase I, INR 2,000 crores for Phase II).
  • Bhumi Pujan has been done; construction has started, with necessary approvals underway.
  • Senior management hiring for the project is nearly complete.
  • Start of production (SOP) for Phase I expected in late FY 2024-25, with stabilization in FY 2025-26.
  • Funding will be largely through internal accruals and equity infusion; bridge financing may be taken if needed.
  • Concurrent investments in R&D (BMS development) and building in-house lithium-ion cell lab facility.
  • Brownfield expansions and debottlenecking planned for lead-acid battery core business with ~INR 400-500 crores annual capex.
  • Nexcharge subsidiary fully acquired to consolidate EV battery-related operations.

How does Exide Industries Ltd rank vs peers in Auto Components?

Pro feature
1Exide Industries Ltd
Rev 2Mar 3

See full Auto Components sector rankings

Unlock with Pro

Want more stocks like Exide Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio